{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T07:12:07Z","timestamp":1716448327678},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.bbrc.2016.04.050","type":"journal-article","created":{"date-parts":[[2016,4,12]],"date-time":"2016-04-12T16:48:43Z","timestamp":1460479723000},"page":"1255-1260","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Transient exposure to proteins SOX2, Oct-4, and NANOG immortalizes exhausted tumor-infiltrating CTLs"],"prefix":"10.1016","volume":"473","author":[{"given":"Anjuli","family":"Bhadurihauck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qianqian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianjun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengguo","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2016.04.050_bib1","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1097\/PPO.0b013e31824d4465","article-title":"Adoptive T-cell therapy using autologous tumor-infiltrating lymphocytes for metastatic melanoma: current status and future outlook","volume":"18","author":"Wu","year":"2012","journal-title":"Cancer J. (Sudbury, Mass.)"},{"key":"10.1016\/j.bbrc.2016.04.050_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.it.2014.02.003","article-title":"Reprogramming antitumor immunity","volume":"35","author":"Crompton","year":"2014","journal-title":"Trends Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nrc3322","article-title":"Paths to stemness: building the ultimate antitumour T cell","volume":"12","author":"Gattinoni","year":"2012","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2016.04.050_bib4","first-page":"75","article-title":"Chimeric antigen receptor-engineered T cells for the treatment of metastatic prostate cancer","volume":"29","author":"Hillerdal","year":"2015","journal-title":"BioDrugs Clin. Immunother. Biopharm. Gene Ther."},{"key":"10.1016\/j.bbrc.2016.04.050_bib5","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/nri3191","article-title":"Adoptive immunotherapy for cancer: harnessing the T cell response","volume":"12","author":"Restifo","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib6","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1002\/stem.1352","article-title":"Concise review: the SOX2-Oct-4 connection: critical players in a much larger interdependent network integrated at multiple levels","volume":"31","author":"Rizzino","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.bbrc.2016.04.050_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.stem.2011.06.007","article-title":"Epigenetic memory and preferential lineage-specific differentiation in induced pluripotent stem cells derived from human pancreatic islet beta cells","volume":"9","author":"Bar-Nur","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2016.04.050_bib8","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.stem.2009.09.008","article-title":"Generation of induced pluripotent stem cells from human cord blood using OCT-4 and SOX2","volume":"5","author":"Giorgetti","year":"2009","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2016.04.050_bib9","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/nm.2446","article-title":"A\u00a0human memory T cell subset with stem cell-like properties","volume":"17","author":"Gattinoni","year":"2011","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2016.04.050_bib10","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.mce.2014.05.025","article-title":"A\u00a0promising approach to iPSC-based cell therapy for diabetic wound treatment: direct lineage reprogramming","volume":"393","author":"Li","year":"2014","journal-title":"Mol. Cell Endocrinol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/ncb2164","article-title":"Conversion of mouse fibroblasts into cardiomyocytes using a direct reprogramming strategy","volume":"13","author":"Efe","year":"2011","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib12","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/nature09591","article-title":"Direct conversion of human fibroblasts to multilineage blood progenitors","volume":"468","author":"Szabo","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.04.050_bib13","series-title":"A\u00a0Protein-induced Pluripotent Cell; Technology Uses Thereof","author":"Wang","year":"2014"},{"key":"10.1016\/j.bbrc.2016.04.050_bib14","doi-asserted-by":"crossref","first-page":"6752","DOI":"10.4049\/jimmunol.178.11.6752","article-title":"Signal 3 availability limits the CD8 T cell response to a solid tumor","volume":"178","author":"Curtsinger","year":"2007","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib15","doi-asserted-by":"crossref","first-page":"2786","DOI":"10.4049\/jimmunol.0803484","article-title":"Programming for CD8 T cell memory development requires IL-12 or type I IFN","volume":"182","author":"Xiao","year":"2009","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4049\/jimmunol.1300652","article-title":"Cutting edge: IL-12 and Type I IFN differentially program CD8 T Cells for programmed death 1 re-expression levels and tumor control","volume":"191","author":"Gerner","year":"2013","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib17","doi-asserted-by":"crossref","first-page":"2756","DOI":"10.4049\/jimmunol.169.5.2756","article-title":"Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma","volume":"169","author":"Liyanage","year":"2002","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib18","doi-asserted-by":"crossref","first-page":"e68183","DOI":"10.1371\/journal.pone.0068183","article-title":"Nicotine inhibits memory CTL programming","volume":"8","author":"Sun","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1016\/j.bbrc.2016.04.050_bib19","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2016.04.050_bib20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.stem.2012.11.002","article-title":"Generation of rejuvenated antigen-specific T cells by reprogramming to pluripotency and redifferentiation","volume":"12","author":"Nishimura","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.bbrc.2016.04.050_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1111\/j.0105-2896.2006.00382.x","article-title":"Signals required for programming effector and memory development by CD8+ T cells","volume":"211","author":"Mescher","year":"2006","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2016.04.050_bib22","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nri778","article-title":"Effector and memory T-cell differentiation: implications for vaccine development","volume":"2","author":"Kaech","year":"2002","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib23","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1084\/jem.20062376","article-title":"Detuning CD8 T cells: down-regulation of CD8 expression, tetramer binding, and response during CTL activation","volume":"204","author":"Xiao","year":"2007","journal-title":"J.\u00a0Exp. Med."},{"key":"10.1016\/j.bbrc.2016.04.050_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/ni969","article-title":"Similarities and differences in CD4+ and CD8+ effector and memory T cell generation","volume":"4","author":"Seder","year":"2003","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib25","doi-asserted-by":"crossref","first-page":"3868","DOI":"10.4049\/jimmunol.141.11.3868","article-title":"Human T cell activation with phytohemagglutinin: the function of IL-6 as an accessory signal","volume":"141","author":"Ceuppens","year":"1988","journal-title":"J.\u00a0Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.cell.2008.01.020","article-title":"Shared principles in NF-kappaB signaling","volume":"132","author":"Hayden","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.04.050_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-065X.2007.00570.x","article-title":"From T-cell activation signals to signaling control of anti-cancer immunity","volume":"220","author":"Cronin","year":"2007","journal-title":"Immunol. Rev."},{"key":"10.1016\/j.bbrc.2016.04.050_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2016.04.050_bib29","series-title":"Kuby Immunology","year":"2007"},{"key":"10.1016\/j.bbrc.2016.04.050_bib30","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/mt.2013.255","article-title":"Immunotherapy-induced CD8+ T cells instigate immune suppression in the tumor","volume":"22","author":"McGray","year":"2014","journal-title":"J.\u00a0Am. Soc. Gene Ther. Mol. Ther."},{"key":"10.1016\/j.bbrc.2016.04.050_bib31","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ghir.2010.02.002","article-title":"The influence of growth hormone replacement on peripheral inflammatory and cardiovascular risk markers in adults with severe growth hormone deficiency","volume":"20","author":"Deepak","year":"2010","journal-title":"Growth Hormone, IGF Res. Off. J. Growth Hormone Res. Soc. Int. IGF Res. Soc."},{"key":"10.1016\/j.bbrc.2016.04.050_bib32","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1038\/nri3307","article-title":"Transcriptional control of effector and memory CD8+ T cell differentiation","volume":"12","author":"Kaech","year":"2012","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nri2888","article-title":"Metabolism, migration and memory in cytotoxic T cells","volume":"11","author":"Finlay","year":"2011","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2016.04.050_bib34","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1742-1241.2004.00284.x","article-title":"Cell proliferation and cell cycle control: a mini review","volume":"58","author":"Golias","year":"2004","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.bbrc.2016.04.050_bib35","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1038\/nrc3090","article-title":"Cyclin D as a therapeutic target in cancer","volume":"11","author":"Musgrove","year":"2011","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.bbrc.2016.04.050_bib36","doi-asserted-by":"crossref","first-page":"5546","DOI":"10.1158\/1078-0432.CCR-12-0977","article-title":"c-Myc and cancer metabolism","volume":"18","author":"Miller","year":"2012","journal-title":"Clin. Cancer Res. Off. J. Am. Assoc. Cancer Res."},{"key":"10.1016\/j.bbrc.2016.04.050_bib37","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00002030-200501030-00004","article-title":"Control of viral rebound through therapeutic immunization with DermaVir","volume":"19","author":"Lisziewicz","year":"2005","journal-title":"AIDS Lond. Engl."},{"key":"10.1016\/j.bbrc.2016.04.050_bib38","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/nature03677","article-title":"c-Myc-regulated microRNAs modulate E2F1 expression","volume":"435","author":"O'Donnell","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2016.04.050_bib39","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/ng1297-498","article-title":"Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT","volume":"17","author":"Weinrich","year":"1997","journal-title":"Nat. Genet."},{"key":"10.1016\/j.bbrc.2016.04.050_bib40","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.stem.2012.12.009","article-title":"Memoirs of a reincarnated T cell","volume":"12","author":"Crompton","year":"2013","journal-title":"Cell Stem Cell"}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16305459?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X16305459?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:48:56Z","timestamp":1692287336000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X16305459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0006291X16305459"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.050","relation":{},"ISSN":["0006-291X"],"issn-type":[{"value":"0006-291X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transient exposure to proteins SOX2, Oct-4, and NANOG immortalizes exhausted tumor-infiltrating CTLs","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2016.04.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}